The Residual Risk Odyssey
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference9 articles.
1. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines;Grundy;J Am Coll Cardiol.,2019
2. Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trials;Willeit;Lancet.,2018
3. Lipoprotein(a), PCSK9 inhibition, and cardiovascular risk;O’Donoghue;Circulation.,2019
4. Effect of alirocumab on lipoprotein(a) and cardiovascular risk after acute coronary syndrome;Bittner;J Am Coll Cardiol.,2020
5. Lipoprotein(a) and benefit of PCSK9 inhibition in patients with nominally controlled LDL cholesterol;Schwartz;J Am Coll Cardiol.,2021
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Lipoprotein(a) metabolomic and proteomic features and atherosclerotic cardiovascular disease in young, healthy adults;2024-05-13
2. Association of Lipoprotein(a) with arterial stiffness: A Mendelian randomization study;European Journal of Clinical Investigation;2024-01-18
3. Focus on lipoprotein(a): The time is now;iLABMED;2023-07-19
4. Lipoprotein(a): a Case for Universal Screening in Youth;Current Atherosclerosis Reports;2023-07-05
5. Phenome-wide Mendelian randomization study of plasma triglyceride levels and 2600 disease traits;eLife;2023-03-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3